Addition of Uterine Cancer to the List of WTC-Related Health Conditions
NIOSH Docket Number 347, CDC-2022-0052
The Administrator of the WTC Health Program proposes the addition of malignant neoplasms of corpus uteri and uterus, part unspecified (uterine cancer) to the List of WTC-Related Health Conditions in 42 CFR § 88.15.
To view the notice and related materials, visit https://www.regulations.gov and enter CDC-2022-0052 in the search field and click “Search.”
Federal Register Notice: World Trade Center (WTC) Health Program; Addition of Uterine Cancer to the List of WTC-Related Health Conditions (cdc.gov) [PDF – 353 KB]
Background Information:
WTC Health Program [2021], Scientific Considerations for Potential Addition of Uterine Cancer to the List of Covered Conditions by the World Trade Center Health Program (Revised): Preliminary Assessment for the World Trade Center Health Program Scientific/Technical Advisory Committee. https://www.cdc.gov/wtc/pdfs/stac/ScientificConsiderationsUterineCancer_STAC_20210928.pdf.
Letter from Dr. Elizabeth Ward, Chair of the STAC, to the Administrator, regarding the STAC’s resolution on the addition of uterine cancer to the List of WTCHP Covered Conditions, received November 29, 2021. https://www.cdc.gov/wtc/pdfs/stac/STAC.Recommendation.Received.29.November.2021.pdf.
Public Comment Period
Comments will be accepted until 11:59 p.m. ET on June 24, 2022.
Written comments, identified by CDC-2022-0052 and docket number NIOSH-347, may be submitted by any of the following methods:
- Federal rulemaking portal: Follow the instructions for submitting comments.
Instructions: All submissions received must include the agency name and docket number. All relevant comments, including any personal information provided, will be posted without change to https://www.regulations.gov
- Mail: NIOSH Docket Office
1090 Tusculum Avenue
MS-C34
Cincinnati, OH 45226